NICOLAS PATEL
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NEPTUNE, NJ NPI 1134577166
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NJ Gilead Sciences, Inc. All categories
General Payments — all program years on this page
$1,042.51
- Category: General Payments
- Program years: PY2021–2023
- Record count: 26
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $262.54 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.54 | 8 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $124.99 | 1 |
| Janssen Biotech, Inc. | $106.55 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.06 | 1 |
| Mallinckrodt Hospital Products Inc. | $13.94 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1025508049 | Gilead Sciences, Inc. | $124.99 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1042871239 | Mallinckrodt Hospital Products Inc. | $13.94 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1055533001 | Takeda Pharmaceuticals U.S.A., Inc. | $17.06 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988266385 | Janssen Biotech, Inc. | $15.16 | 08/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988266393 | Janssen Biotech, Inc. | $15.94 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988266405 | Janssen Biotech, Inc. | $30.60 | 10/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988266413 | Janssen Biotech, Inc. | $29.42 | 06/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 988266425 | Janssen Biotech, Inc. | $15.43 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.